|  | Processed | Not Processed |  | ||||
---|---|---|---|---|---|---|---|---|
Priority | Percent Processed †| Intensified within 3 mos (%) | Baseline Mean Risk Factor Level ‡ | Unadjusted Decline ¶ | Intensified within 3 mos (%) | Baseline Mean Risk Factor Level ‡ | Unadjusted Decline ¶ | Adjusted Difference (Processed – not Processed) During Follow-up (95% CI) € |
1: SBP ≥ 140 mmHg | 45 | 40.5 | 153.4 | 13.1 | 28.8 | 153.0 | 14.1 | 1.01 |
(0.30, 1.75) | ||||||||
2: LDL-c ≥ 130 mg/dL | 46 | 36.3 | 152.8 | 25.9 | 21.0 | 153.4 | 24.0 | -0.6 |
(-3.4, 2.2) | ||||||||
3: A1c ≥ 9% | 47 | 32.6 | 10.3 | 1.0 | 26.7 | 10.2 | 1.0 | -0.03 |
(-0.19, 0.14) | ||||||||
4:SBP 130-139£ | 29 | 27.4 | 138.9 | 5.6 | 21.1 | 138.4 | 6.2 | 1.06 |
(0.44, 1.69) | ||||||||
5: LDL-c 100-129 mg/dL | 30 | 29.2 | 111.2 | 10.4 | 16.8 | 111.4 | 10.0 | 0.63 |
(-0.95, 2.22) | ||||||||
6. A1c 7-8.9% | 28 | 28.9 | 7.6 | -0.1 | 25.3 | 7.5 | -0.1 | -0.03 |
 |  |  |  |  |  |  |  | (-0.09, 0.04) |